
Evidence analysis
Global return-on-investment of COVID-19 vaccines in the first year of the vaccination programme: A model-based economic evaluation
Global Economic Impact of COVID-19 Vaccines in the First Year: Evidence from PLOS Medicine The rapid development and deployment of COVID-19 vaccines were a pivotal part of the global response to the pandemic. A recent study published in…
Read →
Evidence analysis
Nice yellow ball in the sky? Not quite.
What is established The sun is the primary source of light and heat energy for Earth, essential for sustaining life. From our vantage point on Earth, it often appears as a simple yellow ball in the sky. However,…
Read →
Evidence analysis
Time to bring remote workers back in?
What is established Research in organizational behavior and neuroscience demonstrates that in-person work fosters specific social dynamics—such as serendipitous encounters and enhanced neural synchrony—that can drive creativity, trust, and collaboration. This is sometimes referred to as the "Proximity…
Read →
Evidence analysis
‘Unique opportunity’ in study of colorectal cancer
What is established Colorectal cancer (CRC) remains a significant public health challenge as one of the leading causes of cancer-related morbidity and mortality worldwide. Early detection and prevention are critical to improving patient outcomes. Scientific research has increasingly…
Read →
Evidence analysis
Using Cover Art from Emerging Infectious Diseases to Inspire Microbiological Education
What is established The Emerging Infectious Diseases (EID) journal, published by the Centers for Disease Control and Prevention (CDC), has a tradition of featuring artwork on its covers since 1997. These covers visually portray microbial pathogens and their…
Read →
Evidence analysis
Rat Hepatitis E Virus Circulation in Brown Rats from 8 Cities, France, 2021–2023
Rat Hepatitis E Virus Circulation in Brown Rats in France: Evidence and Implications Recent research published in the Emerging Infectious Diseases Journal explores the circulation of rat hepatitis E virus (HEV) among brown rat populations in eight French…
Read →
Evidence analysis
Characteristics of and Clinical Criteria for Oropouche Virus Disease, United States, May 2024–January 2025
Characteristics and Clinical Criteria for Oropouche Virus Disease: Evidence Dossier The Oropouche virus (OROV) outbreak emerging in the Americas during 2024–2025 has prompted in-depth investigation by public health authorities. This dossier summarizes key evidence from a study published…
Read →
Evidence analysis
PSUSA/00009144/202603
Evidence Dossier: Periodic Safety Update Report on Diethylamine-Salicylate and Escin (PSUSA/00009144/202603) What is established The European Medicines Agency (EMA) published a Periodic Safety Update Report Single Assessment (PSUSA) on 5 November 2026 concerning the active substances diethylamine-salicylate and…
Read →
Evidence analysis
PMS Q&A Clinic on Product User Interface (PUI) and Application Programming Interface (API) – December 2026, Online, from 9 December 2026, 09:30 (CET) to 9 December 2026, 10:30 (CET)
What is established The European Medicines Agency (EMA) hosts a public event titled “PMS Q&A Clinic on Product User Interface (PUI) and Application Programming Interface (API)” scheduled for 9 December 2026. This event provides an opportunity for stakeholders,…
Read →
Evidence analysis
From preparedness to response: EU Reference Laboratories for Public Health in action
What is established The European Centre for Disease Prevention and Control (ECDC) highlights the crucial role of strong laboratory infrastructure in Europe’s preparedness and response to communicable disease threats. EU Reference Laboratories for Public Health (EURL-PH) have been…
Read →